Literature DB >> 29445526

Intermittent hypoxia, cardiovascular disease and obstructive sleep apnoea.

Chris D Turnbull1,2.   

Abstract

Obstructive sleep apnoea (OSA) is a common disorder and is associated with cardiovascular disease. Continuous positive airway pressure (CPAP), whilst reducing blood pressure, has not been shown to reduce cardiovascular events when used as a treatment solely for this purpose in patients with previous cardiovascular disease. Developing a better understanding of the mechanisms underlying cardiovascular disease in OSA is important to develop new treatments. Potential causative mechanisms for cardiovascular disease in OSA include arousal induced sympathetic activation, large intrathoracic pressure swings leading to shear stress on the heart and great vessels, and intermittent hypoxia (IH). This review discusses the role of IH, as a major physiological consequence of OSA, in the development of cardiovascular disease.

Entities:  

Keywords:  Sleep apnea; cardiovascular diseases; hypertension; hypoxia; obstructive

Year:  2018        PMID: 29445526      PMCID: PMC5803045          DOI: 10.21037/jtd.2017.10.33

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  65 in total

1.  Hypoxemia alone does not explain blood pressure elevations after obstructive apneas.

Authors:  J Ringler; R C Basner; R Shannon; R Schwartzstein; H Manning; S E Weinberger; J W Weiss
Journal:  J Appl Physiol (1985)       Date:  1990-12

2.  Effect on Intermittent Hypoxia on Plasma Exosomal Micro RNA Signature and Endothelial Function in Healthy Adults.

Authors:  Abdelnaby Khalyfa; Chunling Zhang; Ahamed A Khalyfa; Glen E Foster; Andrew E Beaudin; Jorge Andrade; Patrick J Hanly; Marc J Poulin; David Gozal
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

3.  Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea.

Authors:  Sanja Jelic; Margherita Padeletti; Steven M Kawut; Christopher Higgins; Stephen M Canfield; Duygu Onat; Paolo C Colombo; Robert C Basner; Phillip Factor; Thierry H LeJemtel
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

4.  Mortality risk factors in sleep apnoea: a matched case-control study.

Authors:  Peretz Lavie; Paula Herer; Lena Lavie
Journal:  J Sleep Res       Date:  2007-03       Impact factor: 3.981

5.  Reactive oxygen species contribute to sleep apnea-induced hypertension in rats.

Authors:  Carmen M Troncoso Brindeiro; Ana Q da Silva; Kyan J Allahdadi; Victoria Youngblood; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-31       Impact factor: 4.733

6.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

7.  Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep Apnea.

Authors:  Erik Thunström; Karin Manhem; Annika Rosengren; Yüksel Peker
Journal:  Am J Respir Crit Care Med       Date:  2016-02-01       Impact factor: 21.405

Review 8.  Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies.

Authors:  Hans-Joachim Eisele; Philipp Markart; Richard Schulz
Journal:  Oxid Med Cell Longev       Date:  2015-06-08       Impact factor: 6.543

9.  The Role of Acute Intermittent Hypoxia in Neutrophil-Generated Superoxide, Sympathovagal Balance, and Vascular Function in Healthy Subjects.

Authors:  Germana P L Almeida; Ivani C Trombetta; Felipe X Cepeda; Elaine Hatanaka; Rui Curi; Cristiano Mostarda; Maria C Irigoyen; José A S Barreto-Filho; Eduardo M Krieger; Fernanda M Consolim-Colombo
Journal:  Front Physiol       Date:  2017-01-23       Impact factor: 4.566

10.  Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities.

Authors:  Izolde Bouloukaki; Charalampos Mermigkis; Nikolaos Tzanakis; Eleftherios Kallergis; Violeta Moniaki; Eleni Mauroudi; Sophia E Schiza
Journal:  Mediators Inflamm       Date:  2017-07-31       Impact factor: 4.711

View more
  11 in total

1.  Reperfusion injury to ischemic medullary brain nuclei after stopping continuous positive airway pressure-induced CO2-reduced vasoconstriction in sleep apnea.

Authors:  J Howard Jaster
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  A dual blocker of endothelin A/B receptors mitigates hypertension but not renal dysfunction in a rat model of chronic kidney disease and sleep apnea.

Authors:  Humberto Morales-Loredo; David Jones; Adelaeda Barrera; Perenkita J Mendiola; Joshua Garcia; Carolyn Pace; Minerva Murphy; Nancy L Kanagy; Laura V Gonzalez Bosc
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

3.  Effects of 12 weeks of regular aerobic exercises on autonomic nervous system in obstructive sleep apnea syndrome patients.

Authors:  Hongyan Yang; Yuanhua Liu; Huan Zheng; Guanghui Liu; Aihong Mei
Journal:  Sleep Breath       Date:  2018-10-16       Impact factor: 2.816

4.  Relationship between monocyte to HDL cholesterol ratio and concomitant cardiovascular disease in Chinese Han patients with obstructive sleep apnea.

Authors:  Ning Li; Lei Ren; Jia Hui Wang; Ya Ru Yan; Ying Ni Lin; Qing Yun Li
Journal:  Cardiovasc Diagn Ther       Date:  2019-08

5.  Low oxygen microenvironment and cardiovascular remodeling: Role of dual L/N.type Ca2+ channel blocker.

Authors:  Shrilaxmi Bagali; Savitri M Nerune; R Chandramouli Reddy; Saeed M Yendigeri; Bheemshetty S Patil; Akram A Naikwadi; Raghavendra V Kulkarni; Kusal K Das
Journal:  Indian J Pharmacol       Date:  2020 Sep-Oct       Impact factor: 1.200

6.  Relationships Between Cardinal Features of Obstructive Sleep Apnea and Blood Pressure: A Retrospective Study.

Authors:  Yunyan Xia; Kai You; Yuanping Xiong
Journal:  Front Psychiatry       Date:  2022-04-08       Impact factor: 4.157

7.  Cell-Selective Altered Cargo Properties of Extracellular Vesicles Following In Vitro Exposures to Intermittent Hypoxia.

Authors:  David Sanz-Rubio; Abdelnaby Khalyfa; Zhuanhong Qiao; Jorge Ullate; José M Marin; Leila Kheirandish-Gozal; David Gozal
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

8.  Microbiota Modulates Cardiac Transcriptional Responses to Intermittent Hypoxia and Hypercapnia.

Authors:  Dan Zhou; Jin Xue; Yukiko Miyamoto; Orit Poulsen; Lars Eckmann; Gabriel G Haddad
Journal:  Front Physiol       Date:  2021-06-25       Impact factor: 4.566

9.  Optimal Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Reduces Daytime Resting Heart Rate in Prediabetes: A Randomized Controlled Study.

Authors:  Sushmita Pamidi; Florian Chapotot; Kristen Wroblewski; Harry Whitmore; Tamar Polonsky; Esra Tasali
Journal:  J Am Heart Assoc       Date:  2020-10-01       Impact factor: 5.501

10.  Influence of nocturnal hypoxemia on follow-up course after type B acute aortic syndrome.

Authors:  Pascal Delsart; Jerome Soquet; Adeline Pierache; Maxime Dedeken; Stephanie Fry; Anne Mallart; François Pontana; Richard Azzaoui; Francis Juthier; Jonathan Sobocinski; Claire Mounier-Vehier
Journal:  BMC Pulm Med       Date:  2021-12-06       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.